Section(X) | Body System(W) | Operation(0) | Approach(3) | Body Part(3) | Device / Substance / Technology(A) | Qualifier(3) |
New Technology | Anatomical Regions | Introduction | Percutaneous | Peripheral Vein | Cefiderocol Anti-infective | New Technology Group 3 |
No record found
Change Type | Change Date | Previous Descriptor |
Code Deleted | 09-30-2022 | Introduction of Bezlotoxumab Monoclonal Antibody into Peripheral Vein, Percutaneous Approach, New Technology Group 3 |
Code Added | 10-01-2017 |